11:08 AM EDT, 07/08/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.74% to 1,491.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biotech firm Evaxion ( EVAX ) , which climbed 28% and 3.5%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and internet browser company Opera (OPRA), which increased 2.7% and 2.6%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and brewing company Anheuser-Busch InBev ( BUD ) , which fell 2.5% and 1.3%, respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and consumer goods company Unilever ( UL ) , which were off 0.8% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and pharmaceutical company Silence Therapeutics ( SLN ) , which rose 4.6% and 3.8%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and oil and gas company BP (BP), which were up 2.9% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Trinity Biotech ( TRIB ) , which lost 2.6% and 1.9%, respectively. They were followed by tobacco company British American Tobacco ( BTI ) and biopharmaceutical company Verona Pharma ( VRNA ) , which were down 1.6% and 1.5%, respectively.